Effects of the WHO Labour Care Guide on cesarean section in India: a pragmatic, stepped-wedge, cluster-randomized pilot trial
-
Published:2024-01-30
Issue:2
Volume:30
Page:463-469
-
ISSN:1078-8956
-
Container-title:Nature Medicine
-
language:en
-
Short-container-title:Nat Med
Author:
Vogel Joshua P.ORCID, Pujar Yeshita, Vernekar Sunil S.ORCID, Armari Elizabeth, Pingray Veronica, Althabe Fernando, Gibbons LuzORCID, Berrueta Mabel, Somannavar ManjunathORCID, Ciganda Alvaro, Rodriguez Rocio, Bendigeri Savitri, Kumar Jayashree Ashok, Patil Shruti Bhavi, Karinagannanavar Aravind, Anteen Raveendra R., Mallappa Ramachandrappa Pavithra, Shetty Shukla, Bommanal Latha, Haralahalli Mallesh Megha, Gaddi Suman S., Chikkagowdra Shaila, Raghavendra Bellara, Homer Caroline S. E.ORCID, Lavender Tina, Kushtagi Pralhad, Hofmeyr G. JustusORCID, Derman Richard, Goudar ShivaprasadORCID
Abstract
AbstractCesarean section rates worldwide are rising, driven by medically unnecessary cesarean use. The new World Health Organization Labour Care Guide (LCG) aims to improve the quality of care for women during labor and childbirth. Using the LCG might reduce overuse of cesarean; however, its effects have not been evaluated in randomized trials. We conducted a stepped-wedge, cluster-randomized pilot trial in four hospitals in India to evaluate the implementation of an LCG strategy intervention, compared with routine care. We performed this trial to pilot the intervention and obtain preliminary effectiveness data, informing future research. Eligible clusters were four hospitals with >4,000 births annually and cesarean rates ≥30%. Eligible women were those giving birth at ≥20 weeks’ gestation. One hospital transitioned to intervention every 2 months, according to a random sequence. The primary outcome was the cesarean rate among women in Robson Group 1 (that is, those who were nulliparous and gave birth to a singleton, term pregnancy in cephalic presentation and in spontaneous labor). A total of 26,331 participants gave birth. A 5.5% crude absolute reduction in the primary outcome was observed (45.2% versus 39.7%; relative risk 0.85, 95% confidence interval 0.54–1.33). Maternal process-of-care outcomes were not significantly different, though labor augmentation with oxytocin was 18.0% lower with the LCG strategy. No differences were observed for other health outcomes or women’s birth experiences. These findings can guide future definitive effectiveness trials, particularly in settings where urgent reversal of rising cesarean section rates is needed. Clinical Trials Registry India number: CTRI/2021/01/030695.
Funder
Bill and Melinda Gates Foundation Department of Health | National Health and Medical Research Council Burnet Institute Bill and Melinda Gates Institute for Population and Reproductive Health
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. WHO, UNICEF, UNFPA, World Bank & UNDP. Trends in Maternal Mortality 2000 to 2020 (World Health Organization, 2023). 2. United Nations Inter-Agency Group for Child Mortality Estimation. Levels and Trends in Child Mortality (UNICEF, 2022). 3. Hug, L. et al. Global, regional, and national estimates and trends in stillbirths from 2000 to 2019: a systematic assessment. Lancet 398, 772–785 (2021). 4. Alliance for Maternal Newborn Health Improvement Mortality Study Group. Population-based rates, timing, and causes of maternal deaths, stillbirths, and neonatal deaths in south Asia and sub-Saharan Africa: a multi-country prospective cohort study. Lancet Glob. Health 6, e1297–e1308 (2018). 5. The Global Strategy for Women’s, Children’s and Adolescents’ Health (World Health Organization, 2017).
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|